Brian Van Tine

Brian Van Tine, MD, PhD

Medical Oncology

Top Doctors®

Specializes in

Medical oncology, cancer, sarcoma, soft tissue sarcoma, bone cancer, leiomyosarcoma, liposarcoma

Appointments

Hospital Affiliations

  • Barnes-Jewish Hospital

Experience

Board Certifications

  • Medical Oncology

Academic Title(s)

Professor, Medicine
Division of Oncology
Section of Medical Oncology
Professor, Pediatrics
Director, Developmental Therapeutics (Phase 1) Program
Sarcoma Program Director

Research Interests

Our focus is on understanding the genomics of osteosarcoma, leiomyosarcoma and rarer forms of sarcoma. Using mouse genetics, human tumor xenografting and cancer biology we strive to identify druggable targets that can be used in the clinic.

Publications & Research

View research profile »

Education

Medical Degree

2005 University of Alabama at Birmingham

PhD

2003 University of Alabama at Birmingham

Chief Fellow

2010 Hematology and Oncology, Washington University School of Medicine, St. Louis, Missouri

BS

1995 University of Arizona, Tucson, Arizona

Residency

2006 Barnes-Jewish Hospital, St. Louis, Missouri

Fellowship

2007 Oncology, Washington University School of Medicine, St. Louis, Missouri

Financial Disclosures
  • Hinge Bio
    • Consulting/Advisory Board: $40,000 - $59,999
    • Reporting Date: 05/01/2025

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

Is this your profile? Request an edit »